Oct 02 2024
A new study published in the journal Recent Advances in Drug Delivery and Formulation suggests that nanotechnology could be key to overcoming the challenges of effectively administering cannabis-based medicines. Conducted by researchers from the University of Michigan and the University at Buffalo, the study explores how nanotechnology could improve the bioavailability, solubility, and targeted delivery …
Oct 01 2024
An important new study published in the Journal of Hypertension reveals that long-term treatment with cannabidiol (CBD) can significantly improve cardiovascular health in an animal model of renovascular hypertension. Conducted by researchers from the Federal University of Paraiba and São Paulo State University in Brazil, the study explores CBD’s potential to lower blood pressure, enhance …
Oct 01 2024
A new study published in the journal Translational Psychiatry provide insights into how psilocybin, the active compound in “magic mushrooms”, could aid in the treatment of depression. “Psilocybin has shown promise as a novel pharmacological intervention for treatment of depression, where post-acute effects of psilocybin treatment have been associated with increased positive mood and decreased …
Sep 29 2024
A recent study by researchers at Stanford University School of Medicine and Massachusetts General Hospital has revealed promising results for veterans battling severe treatment-resistant depression (TRD). Published in the Journal of Affective Disorders and online ahead of print by the National Library of Medicine, the study is the first to examine how a single dose …
Sep 27 2024
A new double-blind, placebo-controlled trial published in Kidney Medicine found that a cannabis-containing cream significantly reduced itching in patients with chronic kidney disease (CKD) undergoing hemodialysis. The study, conducted by researchers from Thammasat University in Thailand, involved 60 participants, all experiencing moderate to severe CKD-associated pruritus. The participants were divided into two groups: one received …
Sep 26 2024
A study published in the peer reviewed journal Cannabis and Cannabinoid Research and available online through the U.S. National Library of Medicine explores the effects of Cannabistilbene I (a compound found in cannabis) on Angiotensin II (Ang II)-induced cardiac hypertrophy. The research, conducted by a team at the University of Alberta, examined how Cannabistilbene I …
Sep 25 2024
Researchers at Johns Hopkins University School of Medicine have conducted a longitudinal study exploring how psilocybin experiences impact people’s beliefs about mind perception and their spiritual or metaphysical views. Published recently in the Journal of Psychoactive Drugs, the study involved 657 participants who planned to have a psilocybin experience outside a clinical setting. Participants were …
Sep 21 2024
A new study published in the Journal of Chromatography B highlights a rigorous approach to identifying and quantifying cannabis terpenes and terpenoids, critical secondary metabolites that are believed to play a role in the entourage effect when combined with cannabinoids. The study addresses a key issue in the accurate quantification of terpenes, which are responsible …
Sep 18 2024
According to a study published recently in JAMA Network Open, there was no significant impact on brain activation in individuals using medical marijuana over the course of a year. Titled Year-Long Cannabis Use for Medical Symptoms and Brain Activation During Cognitive Processes and conducted by researchers from Universitas Mercatorum, University of Foggia, University of Bari, and …
Sep 17 2024
A new study of hundreds of people using medical marijuana reported “rapid and significant improvements” in health-related quality of life over the first three months, according to new research led by Philadelphia College of Osteopathic Medicine (PCOM). The study, published in the Journal of Cannabis Research, followed nearly 400 adults who were new to using medical marijuana …
